Inventor · disambiguated record
Kurt Zimmermann
Also filed as: ZIMMERMANN KURT · ZIMMERMANN KURT-UWE
28 granted patents·19 pending applications·175 citations·filing 1997–2025
96Inventor score
Files withARVINAS OPERATIONS INC17BRISTOL MYERS SQUIBB CO15ARVINAS INC4SYMBIOGRUPPE GMBH & CO KG4WITTMAN MARK D2
Top patents by PatentIndex Score
47 records- 0198US11236051B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Feb 1, 2022·9 cites·3 claims
- 0297US10730870B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS INC·Filed 2016·Granted Aug 4, 2020·25 cites·22 claims
- 0394US9273057B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 1, 2016·29 cites·15 claims
- 0494US7534792B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted May 19, 2009·30 cites·14 claims
- 0593US7223757B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 29, 2007·16 cites·21 claims
- 0692US11964945B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Granted Apr 23, 2024·2 cites·26 claims
- 0789US7879855B2Pyrrolotriazine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Feb 1, 2011·10 cites·1 claims
- 0889US2025034096A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 0986US10994015B2EGFR proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2017·Granted May 4, 2021·3 cites·25 claims
- 1085US11427548B2Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2019·Granted Aug 30, 2022·2 cites·15 claims
- 1184US11512083B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2020·Granted Nov 29, 2022·1 cites·17 claims
- 1283US8815840B2Carbazole and carboline kinase inhibitorsPURANDARE ASHOK VINAYAK·Filed 2009·Granted Aug 26, 2014·5 cites·6 claims
- 1383US8263765B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2011·Granted Sep 11, 2012·7 cites·1 claims
- 1482US2025223265A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1579US12441708B2Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2022·Granted Oct 14, 2025·0 cites·20 claims
- 1679US9556178B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Jan 31, 2017·3 cites·7 claims
- 1779US8940736B2Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 27, 2015·3 cites·19 claims
- 1879US2024382599A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2024·Application pending·0 cites
- 1978US12264157B2Compounds and methods for the enhanced degradation of targeted proteinsARVINAS OPERATIONS INC·Filed 2022·Granted Apr 1, 2025·0 cites·24 claims
- 2078US2025313547A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 2177US2025360219A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2025·Application pending·0 cites
- 2274US7470696B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·14 claims
- 2374US7081454B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jul 25, 2006·6 cites·20 claims
- 2474US2021040044A1Compounds and methods for the targeted degradation of androgen receptorARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 2570US8343999B2Thiazolyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Jan 1, 2013·1 cites·4 claims
- 2670US7189716B2Tyrosine kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Mar 13, 2007·4 cites·11 claims
- 2768US2020155690A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 2868US2020155689A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS OPERATIONS INC·Filed 2020·Application pending·0 cites
- 2967US2021220475A1Egfr proteolysis targeting chimeric molecules and associated methods of useARVINAS OPERATIONS INC·Filed 2021·Application pending·0 cites
- 3066US11986531B2Compounds and methods for the targeted degradation of rapidly accelerated fibrosarcoma polypeptidesARVINAS OPERATIONS INC·Filed 2021·Granted May 21, 2024·0 cites·19 claims
- 3165US2018228907A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS INC·Filed 2018·Application pending·0 cites
- 3264US6686385B2Anhydro sugar derivatives of indolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 3, 2004·1 cites·24 claims
- 3363US6610727B2Anhydro sugar derivatives of indolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Aug 26, 2003·1 cites·12 claims
- 3460US6855698B2Topoisomerase I selective cytotoxic sugar derivatives of indolopyrrolocarbazolesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Feb 15, 2005·1 cites·45 claims
- 3560US2018215731A1Cereblon ligands and bifunctional compounds comprising the sameARVINAS INC·Filed 2018·Application pending·0 cites
- 3656US8592579B2Pyrrolotriazine kinase inhibitorsWITTMAN MARK D·Filed 2012·Granted Nov 26, 2013·0 cites·1 claims
- 3756US2018346461A1Compounds and methods for the targeted degradation of androgen receptorARVINAS INC·Filed 2018·Application pending·0 cites
- 3855US2022031803A1Antibacterial composition comprising microcin s and antibioticSYMBIOGRUPPE GMBH & CO KG·Filed 2021·Application pending·0 cites
- 3953US2016108050A1Imidazotriazinecarbonitriles useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 4052US6117849AS-(+)-adenosylmethionine and 3'-azido-2', 3'-dideoxy-nucleoside complexes as potent inhibitors of HIV-replicationSYMBIO HERBORN GROUP GMBH & CO·Filed 1997·Granted Sep 12, 2000·15 cites·23 claims
- 4151US2019160143A1Antibacterial composition comprising microcin s and antibioticSYMBIOGRUPPE GMBH & CO KG·Filed 2018·Application pending·0 cites
- 4247US10550125B2Prodrugs of imidazotriazine compounds as CK2 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 4, 2020·0 cites·5 claims
- 4347US2014314830A1Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec)GUNZER FLORIAN·Filed 2012·Application pending·0 cites
- 4441US10933103B2Dermatologic composition containing Escherichia coli and Enterococcus faecalisSYMBIOGRUPPE GMBH & CO KG·Filed 2018·Granted Mar 2, 2021·0 cites·18 claims
- 4537US2017008934A1Bacterially formed microcin s, a new antimicrobial peptide, effective against pathogenic microorganisms, e.g. enterohemorrhagic escherichia coli (ehec)SYMBIOGRUPPE GMBH & CO KG·Filed 2016·Application pending·0 cites
- 4633US2003230548A1Acid etching mixture having reduced water contentFiled 2002·Application pending·0 cites
- 4730US2002155997A1Kyberdrug as autovaccines with immune-regulating effectsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kurt Zimmermann files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →